Works matching IS 14765810 AND DT 2022 AND VI 20 AND IP 1
Results: 38
Issue Information.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 1, doi. 10.1111/vco.12783
- Publication type:
- Article
Cover Image.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 1, doi. 10.1111/vco.12804
- By:
- Publication type:
- Article
Novel surgical approach to neoplastic lesions in the distal part of the urethra: A pilot cadaver study comparing open and hybrid techniques.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 336, doi. 10.1111/vco.12798
- By:
- Publication type:
- Article
Visualizing the cancer stem‐like properties of canine tumour cells with low proteasome activity.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 324, doi. 10.1111/vco.12779
- By:
- Publication type:
- Article
Atorvastatin preferentially inhibits the growth of high ZEB‐expressing canine cancer cells.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 313, doi. 10.1111/vco.12778
- By:
- Publication type:
- Article
Clinical presentation, treatment and outcome of canine malignant mesothelioma: A retrospective study of 34 cases.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 304, doi. 10.1111/vco.12777
- By:
- Publication type:
- Article
A prospective, multi‐centre, Veterinary Radiation Therapy Oncology Group study reveals potential efficacy of toceranib phosphate (Palladia) as a primary or adjuvant agent in the treatment of canine nasal carcinoma.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 293, doi. 10.1111/vco.12776
- By:
- Publication type:
- Article
Canine anal sac gland carcinoma with regional lymph node metastases treated with sacculectomy and lymphadenectomy: Outcome and possible prognostic factors.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 276, doi. 10.1111/vco.12774
- By:
- Publication type:
- Article
Extensive staging has no prognostic value in dogs with low‐risk mast cell tumours.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 265, doi. 10.1111/vco.12773
- By:
- Publication type:
- Article
Molecular differences in mitochondrial DNA genomes of dogs with malignant mammary tumours.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 256, doi. 10.1111/vco.12772
- By:
- Publication type:
- Article
Risk of bladder cancer and lymphoma in dogs is associated with pollution indices by county of residence.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 246, doi. 10.1111/vco.12771
- By:
- Publication type:
- Article
Response of canine thyroid carcinomas to radioiodine.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 235, doi. 10.1111/vco.12770
- By:
- Publication type:
- Article
Familial follicular cell thyroid carcinomas in a large number of Dutch German longhaired pointers.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 227, doi. 10.1111/vco.12769
- By:
- Publication type:
- Article
Prognostic indicators for naïve canine non‐indolent T‐cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 215, doi. 10.1111/vco.12768
- By:
- Publication type:
- Article
Tumour necrosis factor‐related apoptosis‐inducing ligand (TRAIL) loss in canine mammary carcinoma.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 207, doi. 10.1111/vco.12767
- By:
- Publication type:
- Article
A retrospective comparison of first and second opinion histopathology with patient outcomes in veterinary oncology cases (2011–2019).
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 198, doi. 10.1111/vco.12762
- By:
- Publication type:
- Article
Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti‐CSPG4 vaccination: A retrospective study on 68 cases (2010–2020).
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 189, doi. 10.1111/vco.12761
- By:
- Publication type:
- Article
Clinical outcome of dogs diagnosed with canine inflammatory mammary cancer treated with metronomic cyclophosphamide, a cyclooxygenase‐2 inhibitor and toceranib phosphate.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 179, doi. 10.1111/vco.12760
- By:
- Publication type:
- Article
A retrospective study and survival analysis on bitches with mammary tumours spayed at the same time of mastectomy.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 172, doi. 10.1111/vco.12759
- By:
- Publication type:
- Article
Liquid biopsy can detect BRCA2 gene variants in female dogs with mammary neoplasia.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 164, doi. 10.1111/vco.12758
- By:
- Publication type:
- Article
The prevalence of intra‐tumoral and distant thrombi, as well as tumour‐cell emboli in canine neoplasia.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 154, doi. 10.1111/vco.12757
- By:
- Publication type:
- Article
Increased incidence of gastrointestinal toxicity in canine cancer patients treated with concurrent abdominal radiation therapy and toceranib phosphate.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 142, doi. 10.1111/vco.12756
- By:
- Publication type:
- Article
SLUG is upregulated and induces epithelial mesenchymal transition in canine oral squamous cell carcinoma.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 134, doi. 10.1111/vco.12755
- By:
- Publication type:
- Article
Prostaglandin EP4 receptor mRNA expression in canine lymphoma.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 127, doi. 10.1111/vco.12753
- By:
- Publication type:
- Article
Outcomes and prognostic factors in canine epitheliotropic and nonepitheliotropic cutaneous T‐cell lymphomas.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 118, doi. 10.1111/vco.12752
- By:
- Publication type:
- Article
Molecular characterization of canine SHP2 mutants and anti‐tumour effect of SHP2 inhibitor, SHP099, in a xenograft mouse model of canine histiocytic sarcoma.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 109, doi. 10.1111/vco.12751
- By:
- Publication type:
- Article
Efficacy and adverse events of continuous l‐asparaginase administration for canine large cell lymphoma of presumed gastrointestinal origin.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 102, doi. 10.1111/vco.12749
- By:
- Publication type:
- Article
Canine Oncopanel: A capture‐based, NGS platform for evaluating the mutational landscape and detecting putative driver mutations in canine cancers.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 91, doi. 10.1111/vco.12746
- By:
- Publication type:
- Article
A retrospective analysis of 11 dogs with surface osteosarcoma.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 82, doi. 10.1111/vco.12741
- By:
- Publication type:
- Article
Characterizing the molecular and immune landscape of canine bladder cancer.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 69, doi. 10.1111/vco.12740
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 1, doi. 10.1111/vco.12783
- Publication type:
- Article
The prognostic significance of metabolic tumour volume and total lesion glycolysis for dogs staged for appendicular osteosarcoma with fluorine‐18 fluorodeoxyglucose positron emission tomography/computed tomography.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 59, doi. 10.1111/vco.12706
- By:
- Publication type:
- Article
Thymic epithelial tumours in 51 dogs: Histopathologic and clinicopathologic findings.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 50, doi. 10.1111/vco.12705
- By:
- Publication type:
- Article
Histological and immunohistochemical investigation of canine prostate carcinoma with identification of common intraductal carcinoma component.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 38, doi. 10.1111/vco.12704
- By:
- Publication type:
- Article
Canine presumed glial brain tumours treated with radiotherapy: Is there an inferior outcome in tumours contacting the subventricular zone?
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 29, doi. 10.1111/vco.12703
- By:
- Publication type:
- Article
Feasibility and safety of whole lung irradiation in the treatment of canine appendicular osteosarcoma.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 20, doi. 10.1111/vco.12702
- By:
- Publication type:
- Article
Retrospective assessment of radiation toxicity from a definitive‐intent, moderately hypofractionated image‐guided intensity‐modulated protocol for anal sac adenocarcinoma in dogs.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 8, doi. 10.1111/vco.12701
- By:
- Publication type:
- Article
Prognostic value of sternal lymphadenopathy on malignancy and survival in dogs undergoing splenectomy.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 1, doi. 10.1111/vco.12700
- By:
- Publication type:
- Article